Find Clinical Trial


Trial Status:
Gender:
Condition:

CLINICAL TRIALS

Previous Page        Next Page

Title: A non-interventional, prospective 12 months study to characterize the REAL-life effectiveness and treatment patterns of Secukinumab and current standard of care in patient with chronic plaque psoriAsis eligible for…

CONDITION: Skin

TRIAL STATUS: Active, not recruiting

GENDER: Both males and females

AGE GROUP: 18 years and above

Australian researchers are testing a new oral medication for severe asthma. This is a 52 week study with 11 separate visits and 6 telephone calls. You will be treated at…

CONDITION: Respiratory

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 12 years and above

Australian researchers are testing a potential new treatment for type 2 diabetes mellitus. They are looking for volunteers to participate in this study, which includes up to 4 separate clinic…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 20 years to 80 years

Footwear for self-managing knee osteoarthritis symptoms– volunteers needed! Researchers from the Centre for Health, Exercise and Sports Medicine at The University of Melbourne are conducting a research study to compare two…

CONDITION: Musculoskeletal

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 50 years and above

This project will specifically compare the effects of two different exercise programs for individuals with knee osteoarthritis who have higher body weights and evaluate if they respond differently to either…

CONDITION: Musculoskeletal

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 50 years and above

Pendlebury Research is conducting a clinical study of an investigational wound pain treatment. You may be eligible if you are aged 18 or over, with at least one painful wound…

CONDITION: Skin

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 100 years

This is a 12 week study to test two herbal supplements (Trigonella foenum-graecum Seed Extract and Coccinia Grandis Extract)for Normalizing Elevated (pre-diabetic) Blood Glucose and improving Insulin Sensitivity. It is being conducted in Brisbane…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 70 years

Attention Deficit Hyperactivity Disorder (ADHD) is a common behavioural condition that affects thousands of children and families in Australia. ADHD is a complex disorder involving difficulties with hyperactivity, concentration and…

CONDITION: Other

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 6 years to 17 years

A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial With a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg,…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 10 years to 18 years

A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years and above

The use of NOX66 as a tumour cell-specific sensitiser of radiation therapy may provide greater response to targeted radiation therapy within the tumour cells, with the tumour specific nature of…

CONDITION: Cancer

TRIAL STATUS: Recruiting

GENDER: Males

AGE GROUP: 18 years

Researchers at QBI are looking for participants diagnosed with treatment-resistant Obsessive-Compulsive Disorder (OCD). If you are you between 18 and 70 years of age and live within reasonable travelling distance…

CONDITION: Mental Health

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 70 years

ARE YOU SHY? Do you get anxious in front of others? Do you feel embarrassed if you have to give a speech or perform at a public function? Do you…

CONDITION: Mental Health

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 64 years

If you or someone you know has been diagnosed with cluster headaches, a clinical research study may be an option.   Wesley Medical Research are looking for people who are…

CONDITION: Neurological

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 70 years

An NHMRC funded clinical trial investigating the effects of a herbal medicine extract called Kava for individuals with Generalised Anxiety Disorder (GAD). The KGAD study is an 18-week, double blind,…

CONDITION: Mental Health

TRIAL STATUS: Closed: follow-up continuing

GENDER: Both males and females

AGE GROUP: 18 years to 70 years

Researchers are trialling an investigational medication for the potential treatment of Plaque Psoriasis. By participating in this study you will help to obtain important information about whether this investigational medication…

CONDITION: Skin

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 75 years

This pilot study is investigating the effects of L-theanine, the most abundant amino acid present in tea leaves, as an adjunctive therapy for Generalised Anxiety Disorder (GAD). The ‘TAGS’ study…

CONDITION: Mental Health

TRIAL STATUS: Closed: follow-up continuing

GENDER: Both males and females

AGE GROUP: 18 years to 70 years

A 24-week, double blind placebo study investigating the effects of the amino acid ‘N-acetylcysteine’ (NAC) in Obsessive-Compulsive Disorder (OCD). This NHMRC funded study is currently enrolling participants at 3 trial…

CONDITION: Mental Health

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 70 years

ARE YOU: A pre-diabetic OR type 2 diabetic (diet-controlled or taking Metformin only) Aged between 18 and 70 years Someone with no significant weight change in the last 6 months…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 70 years

This trial is designed to evaluate the safety, tolerability, and preliminary efficacy of intra-tumour injections of SD-101 in combination with intravenous Keytruda (pembrolizumab) in patients with metastatic melanoma. Patients can have progressed…

CONDITION: Cancer

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 70 years


Previous Page        Next Page